Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 9 studies | 41% ± 17% | |
| neuron | 4 studies | 24% ± 9% | |
| GABAergic neuron | 4 studies | 39% ± 18% | |
| retinal ganglion cell | 3 studies | 45% ± 14% | |
| interneuron | 3 studies | 54% ± 30% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 38% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 85% | 23.88 | 191 / 226 | 6% | 0.14 | 26 / 406 |
| bladder | 67% | 20.14 | 14 / 21 | 16% | 0.40 | 81 / 504 |
| ovary | 71% | 8.90 | 127 / 180 | 7% | 0.13 | 32 / 430 |
| kidney | 73% | 6.79 | 65 / 89 | 5% | 0.09 | 44 / 901 |
| breast | 59% | 17.17 | 269 / 459 | 14% | 0.39 | 160 / 1118 |
| brain | 58% | 14.29 | 1542 / 2642 | 5% | 0.09 | 32 / 705 |
| adrenal gland | 32% | 12.16 | 83 / 258 | 28% | 1.80 | 64 / 230 |
| skin | 52% | 18.31 | 933 / 1809 | 8% | 0.35 | 38 / 472 |
| intestine | 57% | 7.70 | 555 / 966 | 2% | 0.05 | 11 / 527 |
| esophagus | 53% | 7.21 | 763 / 1445 | 6% | 0.11 | 11 / 183 |
| prostate | 54% | 6.04 | 132 / 245 | 0% | 0.01 | 2 / 502 |
| stomach | 39% | 4.12 | 140 / 359 | 2% | 0.11 | 7 / 286 |
| uterus | 29% | 2.21 | 50 / 170 | 11% | 0.24 | 52 / 459 |
| heart | 35% | 3.43 | 305 / 861 | 0% | 0 | 0 / 0 |
| thymus | 23% | 1.52 | 149 / 653 | 2% | 0.04 | 15 / 605 |
| lung | 5% | 0.24 | 29 / 578 | 16% | 0.43 | 187 / 1155 |
| adipose | 21% | 1.33 | 247 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 20% | 1.61 | 264 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 7% | 0.41 | 23 / 328 | 12% | 0.26 | 21 / 178 |
| muscle | 4% | 0.23 | 29 / 803 | 0% | 0 | 0 / 0 |
| spleen | 2% | 0.11 | 6 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
| peripheral blood | 2% | 0.09 | 16 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0019221 | Biological process | cytokine-mediated signaling pathway |
| GO_1905606 | Biological process | regulation of presynapse assembly |
| GO_0007417 | Biological process | central nervous system development |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004908 | Molecular function | interleukin-1 receptor activity |
| GO_0003953 | Molecular function | NAD+ nucleosidase activity |
| GO_0061809 | Molecular function | NAD+ nucleotidase, cyclic ADP-ribose generating |
| GO_0004910 | Molecular function | interleukin-1, type II, blocking receptor activity |
| Gene name | IL1RAPL2 |
| Protein name | X-linked interleukin-1 receptor accessory protein-like 2 (IL-1 receptor accessory protein-like 2) (IL-1-RAPL-2) (IL-1RAPL-2) (IL1RAPL-2) (EC 3.2.2.6) (IL1RAPL-2-related protein) (Interleukin-1 receptor 9) (IL-1R-9) (IL-1R9) (Three immunoglobulin domain-containing IL-1 receptor-related 1) (TIGIRR-1) |
| Synonyms | IL1R9 |
| Description | |
| Accessions | Q9NP60 ENST00000372582.6 |
